J P Greer|M C Kinney|T P Loughran - JoVE Visualize

Showing results (91-100 of 185) with videos related to

Pageof 19

Sort By:

Bone Marrow Transplantation|November 1, 1988

Use of the BCR probe to demonstrate extramedullary recurrence of CGL with a T cell lymphoid phenotype following bone marrow transplantationL Giannone, J A Whitlock, M C Kinney, et al.

Archives of Pathology & Laboratory Medicine|August 1, 1997

Disseminated toxoplasmosis. Unusual presentations in the immunocompromised hostS J Arnold, M C Kinney, M S McCormick, et al.

Cancer|May 15, 1987

Splenectomy for end-stage chronic lymphocytic leukemiaR S Stein, D Weikert, V Reynolds, et al.

Leukemia & Lymphoma|June 1, 1997

Absence of human herpes virus 8 DNA sequences in large granular lymphocyte (LGL) leukemiaT P Loughran, L Abbott, T C Gentile, et al.

Leukemia|July 1, 1995

Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytesR Zambello, T P Loughran, L Trentin, et al.

Blood|July 1, 1990

Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantationT P Loughran, K Sullivan, T Morton, et al.

Journal of Cellular Biochemistry|May 1, 1997

Structure and function analysis of the human myeloid cell nuclear differentiation antigen promoter: evidence for the role of Sp1 and not of c-Myb or PU.1 in myelomonocytic lineage-specific expressionW Y Kao, J A Briggs, M C Kinney, et al.

Human Pathology|February 24, 1999

The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical featuresR E Felgar, K E Salhany, W R Macon, et al.

American Journal of Clinical Pathology|May 1, 1991

Leu-22 (L60). A more sensitive marker than UCHL1 for peripheral T-cell lymphomas, particularly large-cell typesW R Macon, T T Casey, M C Kinney, et al.

Leukemia & Lymphoma|September 1, 1996

Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot studyR S Stein, J P Greer, J M Flexner, et al.

Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:

Pageof 19

Bone Marrow Transplantation|November 1, 1988

Use of the BCR probe to demonstrate extramedullary recurrence of CGL with a T cell lymphoid phenotype following bone marrow transplantationL Giannone, J A Whitlock, M C Kinney, et al.

Archives of Pathology & Laboratory Medicine|August 1, 1997

Disseminated toxoplasmosis. Unusual presentations in the immunocompromised hostS J Arnold, M C Kinney, M S McCormick, et al.

Cancer|May 15, 1987

Splenectomy for end-stage chronic lymphocytic leukemiaR S Stein, D Weikert, V Reynolds, et al.

Leukemia & Lymphoma|June 1, 1997

Absence of human herpes virus 8 DNA sequences in large granular lymphocyte (LGL) leukemiaT P Loughran, L Abbott, T C Gentile, et al.

Leukemia|July 1, 1995

Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytesR Zambello, T P Loughran, L Trentin, et al.

Blood|July 1, 1990

Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantationT P Loughran, K Sullivan, T Morton, et al.

Journal of Cellular Biochemistry|May 1, 1997

Structure and function analysis of the human myeloid cell nuclear differentiation antigen promoter: evidence for the role of Sp1 and not of c-Myb or PU.1 in myelomonocytic lineage-specific expressionW Y Kao, J A Briggs, M C Kinney, et al.

Human Pathology|February 24, 1999

The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical featuresR E Felgar, K E Salhany, W R Macon, et al.

American Journal of Clinical Pathology|May 1, 1991

Leu-22 (L60). A more sensitive marker than UCHL1 for peripheral T-cell lymphomas, particularly large-cell typesW R Macon, T T Casey, M C Kinney, et al.

Leukemia & Lymphoma|September 1, 1996

Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot studyR S Stein, J P Greer, J M Flexner, et al.

Pageof 19